Opus Genetics, Inc.
IRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001228627
In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Opus Genetics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- 0 vs. Q2 2022
- Shares held
- 2.83M
- +436.6K (+18.3%) vs. Q2 2022
- Total value
- $5.69M
- +$1.10M (+24.0%) vs. Q2 2022
- New holders
- 6
- 7 more added
- Sold out
- 6
- 9 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IRD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 103 | $236.4M |
| Q1 2026 | 79 | $203.8M |
| Q4 2025 | 59 | $55.9M |
| Q3 2025 | 48 | $31.9M |
| Q2 2025 | 43 | $16.5M |
| Q1 2025 | 46 | $14.7M |
| Q4 2024 | 43 | $4.38M |
| Q3 2024 | 38 | $3.32M |
| Q2 2024 | 37 | $4.13M |
| Q1 2024 | 49 | $6.78M |
| Q4 2023 | 50 | $11.2M |
| Q3 2023 | 50 | $12.6M |
| Q2 2023 | 49 | $16.0M |
| Q1 2023 | 41 | $13.0M |
| Q4 2022 | 35 | $10.9M |
| Q3 2022 | 37 | $5.69M |
| Q2 2022 | 38 | $4.62M |
| Q1 2022 | 41 | $6.69M |
| Q4 2021 | 40 | $8.07M |
| Q3 2021 | 30 | $8.62M |
| Q2 2021 | 36 | $5.61M |
| Q1 2021 | 27 | $5.27M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Opus Genetics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 48 | $0 | 0.00% | −8,723−99.5% | Reduced |
| Royal Bank of Canada | 5 | $0 | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 2 | $0 | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 600 | $1.00K | 0.00% | 00.0% | Unchanged |
| Aspire Private Capital, LLC | 400 | $1.00K | 0.00% | 00.0% | Unchanged |
| CarsonAllaria Wealth Management, Ltd. | 1,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,700 | $3.00K | 0.00% | −766−31.1% | Reduced |
| Capital Analysts, LLC | 1,636 | $3.00K | 0.00% | +1,636 | New |
| Wells Fargo & Company | 2,908 | $6.00K | 0.00% | +4+0.1% | Added |
| Tower Research Capital LLC (TRC) | 3,392 | $7.00K | 0.00% | +256+8.2% | Added |
| Kestra Private Wealth Services, LLC | 10,000 | $20.0K | 0.00% | 00.0% | Unchanged |
| Stokes Family Office, LLC | 12,120 | $24.0K | 0.00% | 00.0% | Unchanged |
| Cornerstone Capital, Inc. | 13,857 | $28.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna Fundamental Investments, LLC | 15,105 | $30.0K | 0.00% | +15,105 | New |
| Charles Schwab Investment Management Inc | 14,928 | $31.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 15,600 | $31.0K | 0.00% | +15,600 | New |
| Bedel Financial Consulting, Inc. | 15,000 | $31.0K | 0.01% | +15,000 | New |
| Two Sigma Advisers, LP | 18,200 | $37.0K | 0.00% | −134,200−88.1% | Reduced |
| Captrust Financial Advisors | 19,501 | $39.0K | 0.00% | +18,001+1,200.1% | Added |
| Warberg Asset Management LLC | 21,000 | $42.0K | 0.01% | −3,200−13.2% | Reduced |
| Northern Trust Corp | 22,281 | $45.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 24,463 | $49.0K | 0.00% | −11,119−31.2% | Reduced |
| Diametric Capital, LP | 24,548 | $49.0K | 0.02% | −9,808−28.5% | Reduced |
| Eidelman Virant Capital | 25,000 | $51.0K | 0.04% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 25,576 | $51.0K | 0.00% | +25,576 | New |
| Ameriprise Financial Inc | 30,099 | $60.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 32,603 | $66.0K | 0.00% | −2,063−6.0% | Reduced |
| Comerica Bank | 30,000 | $68.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 36,593 | $74.0K | 0.00% | −8,040−18.0% | Reduced |
| State Street Corp | 62,173 | $125.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 66,717 | $135.0K | 0.00% | −4,452−6.3% | Reduced |
| Geode Capital Management, LLC | 151,569 | $304.0K | 0.00% | +4,110+2.8% | Added |
| Renaissance Technologies LLC | 206,901 | $416.0K | 0.00% | +8,711+4.4% | Added |
| Richmond Brothers, Inc. | 320,332 | $641.0K | 0.71% | +9,212+3.0% | Added |
| MAI Capital Management | 356,948 | $717.0K | 0.01% | +356,948 | New |
| Rice Hall James & Associates, LLC | 540,348 | $1.09M | 0.06% | +212,854+65.0% | Added |
| Vanguard Group Inc | 703,088 | $1.41M | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −17,802−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −16,458−100.0% | Sold out |
| MCF Advisors LLC | 0 | $0 | 0.00% | −10,565−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −10,005−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −9,002−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Frontier Wealth Management LLC | – | – | – | – | Not filed |